BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31207912)

  • 1. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?
    Butler MG
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 15q11.2 BP1-BP2 Microdeletion (
    Rafi SK; Butler MG
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.
    Butler MG
    J Intellect Disabil Res; 2017 Jun; 61(6):568-579. PubMed ID: 28387067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families.
    Baldwin I; Shafer RL; Hossain WA; Gunewardena S; Veatch OJ; Mosconi MW; Butler MG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review.
    Butler MG
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 15q11.2 BP1-BP2 microdeletion syndrome: a review.
    Cox DM; Butler MG
    Int J Mol Sci; 2015 Feb; 16(2):4068-82. PubMed ID: 25689425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-resistant psychotic symptoms and the 15q11.2 BP1-BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature.
    Farrell M; Lichtenstein M; Harner MK; Crowley JJ; Filmyer DM; Lázaro-Muñoz G; Dietterich TE; Bruno LM; Shaughnessy RA; Biondi TF; Burkholder S; Donmoyer J; Berg JS; Szatkiewicz J; Sullivan PF; Josiassen RC
    Transl Psychiatry; 2020 Jan; 10(1):42. PubMed ID: 32066678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound.
    Chen CP; Chang SY; Wang LK; Chang TY; Chern SR; Wu PS; Chen SW; Lai ST; Chuang TY; Yang CW; Town DD; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):730-733. PubMed ID: 30342661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
    Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
    Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.
    Doornbos M; Sikkema-Raddatz B; Ruijvenkamp CA; Dijkhuizen T; Bijlsma EK; Gijsbers AC; Hilhorst-Hofstee Y; Hordijk R; Verbruggen KT; Kerstjens-Frederikse WS; van Essen T; Kok K; van Silfhout AT; Breuning M; van Ravenswaaij-Arts CM
    Eur J Med Genet; 2009; 52(2-3):108-15. PubMed ID: 19328872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and magnesium levels: Novel insights in 15q11.2 BP1-BP2 copy number variants.
    Meossi C; Carrer A; Ciaccio C; Estienne M; Silipigni R; Sciacca FL; Pantaleoni C; D'Arrigo S; Milani D
    J Intellect Disabil Res; 2023 Jul; 67(7):679-689. PubMed ID: 37129092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay.
    Chen CP; Lin SP; Lee CL; Chern SR; Wu PS; Chen YN; Chen SW; Wang W
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):93-97. PubMed ID: 28254235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
    Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
    Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons.
    Chai JH; Locke DP; Greally JM; Knoll JH; Ohta T; Dunai J; Yavor A; Eichler EE; Nicholls RD
    Am J Hum Genet; 2003 Oct; 73(4):898-925. PubMed ID: 14508708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Perinatal and Early Life Outcomes following 15q11.2 CNV Diagnosis.
    Chu FC; Shaw SW; Lee CH; Lo LM; Hsu JJ; Hung TH
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the RNA-binding protein interaction with the mRNAs encoded from human chromosome 15q11.2 BP1-BP2 microdeletion region.
    Biswal SR; Singh M; Dwibedy SLL; Kumari S; Muthuswamy S; Kumar A; Kumar S
    Funct Integr Genomics; 2023 May; 23(2):174. PubMed ID: 37219715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine ultrasound phenotyping, molecular characteristics, and postnatal follow-up of fetuses with the 15q11.2 BP1-BP2 microdeletion syndrome: a single-center, retrospective clinical study.
    Cai M; Lv A; Zhao W; Xu L; Lin N; Huang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):23. PubMed ID: 38172840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A report on seven fetal cases associated with 15q11-q13 microdeletion and microduplication.
    Huang X; Chen J; Hu W; Li L; He H; Guo H; Liao Q; Ye M; Tang D; Dai Y
    Mol Genet Genomic Med; 2021 Mar; 9(3):e1605. PubMed ID: 33538077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prader-Willi syndrome, deletion subtypes, and magnesium: Potential impact on clinical findings.
    Butler MG; Cowen N; Bhatnagar A
    Am J Med Genet A; 2022 Nov; 188(11):3278-3286. PubMed ID: 36190479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Diversity of 15q11.2 BP1-BP2 Deletion in Three Korean Families with Development Delay and/or Intellectual Disability: A Case Series and Literature Review.
    Han JY; Park J
    Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33921555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.